Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinisk Tandtekniker Lizette Schandorff ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2%   Bankruptcy risk   9.7% 6.3% 5.8% 4.8% 29.4% 29.0% 18.4% 15.6%   Credit score (0-100)   27 39 41 45 1 1 7 12   Credit rating   BB BBB BBB BBB C B B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   615 452 476 686 0.0 0.0 0.0 0.0   EBITDA   166 16.6 -13.5 348 0.0 0.0 0.0 0.0   EBIT   166 16.6 -13.5 348 0.0 0.0 0.0 0.0   Pre-tax profit (PTP)   147.0 12.8 -19.1 345.3 0.0 0.0 0.0 0.0   Net earnings   114.6 9.6 -15.3 268.7 0.0 0.0 0.0 0.0   Pre-tax profit without non-rec. items   147 12.8 -19.1 345 0.0 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   14.5 24.1 8.9 278 0.0 0.0 0.0 0.0   Interest-bearing liabilities   94.1 123 169 15.1 0.0 0.0 0.0 0.0   Balance sheet total (assets)   306 353 311 471 0.0 0.0 0.0 0.0   Net Debt   -51.8 -23.8 84.6 -202 0.0 0.0 0.0 0.0     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   615 452 476 686 0.0 0.0 0.0 0.0   Gross profit growth   16.1% -26.4% 5.1% 44.3% -100.0% 0.0% 0.0% 0.0%   Employees   1 1 1 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   306 353 311 471 0 0 0 0   Balance sheet change%   8.2% 15.6% -12.1% 51.5% -100.0% 0.0% 0.0% 0.0%   Added value   165.5 16.6 -13.5 348.0 0.0 0.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 0.0 0.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.9% 3.7% -2.8% 50.7% 0.0% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   48.1% 5.1% -4.1% 89.1% 0.0% 0.0% 0.0% 0.0%   ROI %   93.9% 13.1% -8.3% 147.8% 0.0% 0.0% 0.0% 0.0%   ROE %   77.2% 49.6% -92.6% 187.6% 0.0% 0.0% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   4.8% 6.8% 2.8% 59.0% 0.0% 0.0% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -31.3% -143.6% -625.7% -58.0% 0.0% 0.0% 0.0% 0.0%   Gearing %   647.7% 511.9% 1,914.2% 5.5% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.0% 3.6% 3.9% 3.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   1.0 1.0 0.9 3.7 0.0 0.0 0.0 0.0   Current Ratio   1.0 1.0 0.9 3.7 0.0 0.0 0.0 0.0   Cash and cash equivalent   145.9 147.3 84.9 217.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   8.4 -11.2 -29.7 315.5 0.0 0.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   166 17 -14 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   166 17 -14 0 0 0 0 0   EBIT / employee   166 17 -14 0 0 0 0 0   Net earnings / employee   115 10 -15 0 0 0 0 0